Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season?Zacks Investment Research • 04/25/25
Curious about Pfizer (PFE) Q1 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 04/24/25
Guardant Health Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy PlatformBusiness Wire • 04/24/25
Pfizer Advances Bold Vision for Future of Cancer Care at the ASCO 2025 Annual MeetingBusiness Wire • 04/23/25
Pfizer Earnings Preview: Pharma May Plumb New Depths After Obesity Drug DebacleSeeking Alpha • 04/23/25
S&P 500 Sell-Off: 2 Ultra-High-Yield Dividend Stocks That Make for No-Brainer BuysThe Motley Fool • 04/23/25
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 04/22/25
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (April 2025)24/7 Wall Street • 04/21/25
If You Like Schwab's SCHD, You Can't Miss These Stocks With Even Higher Yields24/7 Wall Street • 04/18/25
Pfizer Abandons Its Leading Weight Loss Candidate. Should You Sell the Stock?The Motley Fool • 04/18/25
3 Magnificent S&P 500 Dividend Stocks Down 11% to 63% to Buy and Hold ForeverThe Motley Fool • 04/18/25